Angelman syndrome DNA Methylation Mapping in Genetic Syndromes Leads to Disease-Specific Episignatures Researchers identified 34 episignatures that could be used for diagnostic testing and the interpretation of ambiguous genetic test results. Ovid Therapeutics, NeuroPointDX Form Biomarker Partnership The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome. BioArray Briefs: 2009.03.31 Premium Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen Baylor to Use Illumina's Infinium Products in Developmental Diseases Studies Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases. Quest Licenses Another Epigenomics Biomarker Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker. Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.